These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 20005639

  • 1. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.
    Houweling AC, Philippens ME, Dijkema T, Roesink JM, Terhaard CH, Schilstra C, Ten Haken RK, Eisbruch A, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1259-65. PubMed ID: 20005639
    [Abstract] [Full Text] [Related]

  • 2. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T, Terhaard CH, Roesink JM, Braam PM, van Gils CH, Moerland MA, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1101-9. PubMed ID: 18472355
    [Abstract] [Full Text] [Related]

  • 3. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009
    [Abstract] [Full Text] [Related]

  • 4. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S, Iaccarino G, Pasciuti K, Soriani A, Benassi M, Arcangeli G, Giovinazzo G, Benassi M, Marucci L.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1252-9. PubMed ID: 19251097
    [Abstract] [Full Text] [Related]

  • 5. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
    Scrimger RA, Stavrev P, Parliament MB, Field C, Thompson H, Stavreva N, Fallone BG.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):178-85. PubMed ID: 15337554
    [Abstract] [Full Text] [Related]

  • 6. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
    Hey J, Setz J, Gerlach R, Vordermark D, Gernhardt CR, Kuhnt T.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1475-80. PubMed ID: 19515505
    [Abstract] [Full Text] [Related]

  • 7. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Strigari L, Benassi M, Arcangeli G, Bruzzaniti V, Giovinazzo G, Marucci L.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):269-76. PubMed ID: 20100642
    [Abstract] [Full Text] [Related]

  • 8. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
    Eisbruch A, Dawson LA, Kim HM, Bradford CR, Terrell JE, Chepeha DB, Teknos TN, Anzai Y, Marsh LH, Martel MK, Ten Haken RK, Wolf GT, Ship JA.
    Acta Otorhinolaryngol Belg; 1999 May 01; 53(3):271-5. PubMed ID: 10635407
    [Abstract] [Full Text] [Related]

  • 9. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
    Semenenko VA, Li XA.
    Phys Med Biol; 2008 Feb 07; 53(3):737-55. PubMed ID: 18199912
    [Abstract] [Full Text] [Related]

  • 10. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):663-73. PubMed ID: 14967418
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 12. Long-term parotid gland function after radiotherapy.
    Braam PM, Roesink JM, Moerland MA, Raaijmakers CP, Schipper M, Terhaard CH.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):659-64. PubMed ID: 15936542
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.
    Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA.
    Int J Radiat Oncol Biol Phys; 1999 Oct 01; 45(3):577-87. PubMed ID: 10524409
    [Abstract] [Full Text] [Related]

  • 18. A Bayesian mixture model relating dose to critical organs and functional complication in 3D conformal radiation therapy.
    Johnson TD, Taylor JM, Ten Haken RK, Eisbruch A.
    Biostatistics; 2005 Oct 01; 6(4):615-32. PubMed ID: 15917377
    [Abstract] [Full Text] [Related]

  • 19. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van den Bogaert W.
    Radiother Oncol; 2004 Aug 01; 72(2):119-27. PubMed ID: 15297131
    [Abstract] [Full Text] [Related]

  • 20. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):14-22. PubMed ID: 17869018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.